Following tumour exome sequencing, Vivan Therapeutics generates fruit fly avatars of patients incorporating tumourigenic mutations. With robotics, they evaluate more than 1,200 FDA approved drugs - including non-cancer drugs - to identify drug combinations that significantly improve mortality in the avatar population. They then present the drug combinations to a tumour board who make the best treatment recommendation for the patient.
Focus: Drug discovery platform
Team: Laura Towart